Arthur van Gameren

866 total citations
14 papers, 711 citations indexed

About

Arthur van Gameren is a scholar working on Epidemiology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Arthur van Gameren has authored 14 papers receiving a total of 711 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 10 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Oncology. Recurrent topics in Arthur van Gameren's work include Neuroendocrine Tumor Research Advances (11 papers), Radiopharmaceutical Chemistry and Applications (10 papers) and Lung Cancer Research Studies (5 papers). Arthur van Gameren is often cited by papers focused on Neuroendocrine Tumor Research Advances (11 papers), Radiopharmaceutical Chemistry and Applications (10 papers) and Lung Cancer Research Studies (5 papers). Arthur van Gameren collaborates with scholars based in Netherlands, United States and Switzerland. Arthur van Gameren's co-authors include Marion de Jong, Eric P. Krenning, Bert F. Bernard, Willem H. Bakker, Wout A. P. Breeman, Jack L. Erion, Theo J. Visser, Helmut R. Mäcke, Michelle Schmidt and Ananth Srinivasan and has published in prestigious journals such as International Journal of Cancer, Urban Studies and European Journal of Nuclear Medicine and Molecular Imaging.

In The Last Decade

Arthur van Gameren

14 papers receiving 677 citations

Peers

Countries citing papers authored by Arthur van Gameren

Since Specialization

Citations

This map shows the geographic impact of Arthur van Gameren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arthur van Gameren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arthur van Gameren more than expected).

Fields of papers citing papers by Arthur van Gameren

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arthur van Gameren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arthur van Gameren. The network helps show where Arthur van Gameren may publish in the future.

Co-authorship network of co-authors of Arthur van Gameren

This figure shows the co-authorship network connecting the top 25 collaborators of Arthur van Gameren. A scholar is included among the top collaborators of Arthur van Gameren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arthur van Gameren. Arthur van Gameren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Optimised labeling, preclinical and initial clinical aspects of CCK-2 receptor-targeting with 3 radiolabeled peptides 2008 ·Nuclear Medicine and Biology ·Wouter A.P. Breeman, (unknown), Erik de Blois, Arthur van Gameren, Marleen Melis, Marion de Jong, Θεοδοσία Μάινα, Berthold A. Nock, Jack L. Erion, Helmut R. Mäcke, E. P. Krenning	57
2	[99mTc]Demotate 2 in the detection of sst2-positive tumours: a preclinical comparison with [111In]DOTA-tate 2006 ·European Journal of Nuclear Medicine and Molecular Imaging ·Θεοδοσία Μάινα, Berthold A. Nock, Paul Cordopatis, Bert F. Bernard, Wout A. P. Breeman, Arthur van Gameren, (unknown), Jean–Claude Reubi, Eric P. Krenning, Marion de Jong	20
3	Radiolabeled RGD-DTPA-Tyr ³ -Octreotate for Receptor-Targeted Radionuclide Therapy 2004 ·Cancer Biotherapy and Radiopharmaceuticals ·Bert F. Bernard, Astrid Capello, Martin van Hagen, Wout A. P. Breeman, Ananth Srinivasan, Michelle Schmidt, Jack L. Erion, Arthur van Gameren, Eric P. Krenning, Marion de Jong	29
4	Uptake of [111In-DTPA0]octreotide in the rat kidney is inhibited by colchicine and not by fructose. 2004 ·PubMed ·Edgar J. Rolleman, Eric P. Krenning, Arthur van Gameren, Bert F. Bernard, Marion de Jong	29
5	Inhomogeneous localization of radioactivity in the human kidney after injection of [(111)In-DTPA]octreotide. 2004 ·PubMed ·Marion de Jong, Roelf Valkema, Arthur van Gameren, Hester van Boven, Axel Bex, (unknown), (unknown), Meike Körner, Jean–Claude Reubi, Eric P. Krenning	57
6	The addition of DTPA to [177Lu-DOTA0,Tyr3]octreotate prior to administration reduces rat skeleton uptake of radioactivity 2003 ·European Journal of Nuclear Medicine and Molecular Imaging ·Wouter A.P. Breeman, (unknown), Bert F. Bernard, Arthur van Gameren, Jack L. Erion, Theo J. Visser, Eric P. Krenning, Marion de Jong	63
7	Effect of omeprazole on renal uptake of 111-In-DTPA-octreotide 2001 ·European Journal of Nuclear Medicine and Molecular Imaging ·Raffaella Barone, Stanislas Pauwels, François Jamar, Marion de Jong, (unknown), Arthur van Gameren, (unknown)	4
8	[177Lu-DOTA0,Tyr3]octreotate for somatostatin receptor-targeted radionuclide therapy 2001 ·International Journal of Cancer ·Marion de Jong, Wout A. P. Breeman, (unknown), Willem H. Bakker, (unknown), Arthur van Gameren, (unknown), Jack L. Erion, Michelle Schmidt, Ananth Srinivasan, Eric P. Krenning	172
9	Tumor response after [(90)Y-DOTA(0),Tyr(3)]octreotide radionuclide therapy in a transplantable rat tumor model is dependent on tumor size. 2001 ·PubMed ·Marion de Jong, Wout A. P. Breeman, Bert F. Bernard, Willem H. Bakker, Theo J. Visser, P.P.M. Kooij, Arthur van Gameren, Eric P. Krenning	81
10	Octreotide Radionuclide Therapy in a Transplantable Rat Tumor Model Is Dependent on Tumor Size 2001 ·Marion de Jong, Bert F. Bernard, Willem H. Bakker, Theo J. Visser, Arthur van Gameren, Eric P. Krenning	2
11	[177Lu‐DOTA0,Tyr3]octreotate for somatostatin receptor‐targeted radionuclide therapy 2001 ·International Journal of Cancer ·Marion de Jong, Wout A. P. Breeman, Bert F. Bernard, Willem H. Bakker, (unknown), Arthur van Gameren, (unknown), Jack L. Erion, Michelle Schmidt, Ananth Srinivasan, Eric P. Krenning	13
12	Tumour uptake of the radiolabelled somatostatin analogue [DOTA 0 ,TYR 3 ]octreotide is dependent on the peptide amount 1999 ·European Journal of Nuclear Medicine and Molecular Imaging ·Marion de Jong, Wout A. P. Breeman, Bert F. Bernard, Arthur van Gameren, (unknown), Willem H. Bakker, Marcel E. van der Pluijm, Theo J. Visser, Helmut R. Mäcke, Eric P. Krenning	84
13	Internalization of radiolabelled [DTPA0]octreotide and [DOTA0, Tyr3]octreotide 1998 ·Nuclear Medicine Communications ·Marion de Jong, Bert F. Bernard, Elza de Bruin, Arthur van Gameren, Willem H. Bakker, T.J. Visser, Helmut R. Mäcke, E. P. Krenning	99
14	A Study of the Formal Structure of J. W. Forrester's Urban Dynamics Model 1978 ·Urban Studies ·Larissa T. Beumer, Arthur van Gameren, Bart van der Hee, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact